Supplementary Table S2 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
Published in 2023 by
Jason J. Luke,
Sarina A. Piha Paul 
,
Theresa Medina,
Claire F. Verschraegen,
Mary Varterasian,
Aoife M. Brennan ,
Richard J. Riese,
Anna Sokolovska,
James Strauss,
David L. Hava,
Filip Janku
,
Theresa Medina,
Claire F. Verschraegen,
Mary Varterasian,
Aoife M. Brennan ,
Richard J. Riese,
Anna Sokolovska,
James Strauss,
David L. Hava,
Filip Janku
